GT101 Injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GT101 Injection, covering 2025-02-21 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer [Phase 2]